306 related articles for article (PubMed ID: 11356926)
21. Stereoselective hepatobiliary transport of the quinolone antibiotic grepafloxacin and its glucuronide in the rat.
Sasabe H; Kato Y; Tsuji A; Sugiyama Y
J Pharmacol Exp Ther; 1998 Feb; 284(2):661-8. PubMed ID: 9454812
[TBL] [Abstract][Full Text] [Related]
22. Dose-dependent inhibition of transporter-mediated hepatic uptake and biliary excretion of methotrexate by cyclosporine A in an isolated perfused rat liver model.
Parasrampuria R; Mehvar R
J Pharm Sci; 2010 Dec; 99(12):5060-9. PubMed ID: 20821379
[TBL] [Abstract][Full Text] [Related]
23. Carrier-mediated mechanism for the biliary excretion of the quinolone antibiotic grepafloxacin and its glucuronide in rats.
Sasabe H; Tsuji A; Sugiyama Y
J Pharmacol Exp Ther; 1998 Mar; 284(3):1033-9. PubMed ID: 9495864
[TBL] [Abstract][Full Text] [Related]
24. Multiple transport systems for organic anions across the bile canalicular membrane.
Sathirakul K; Suzuki H; Yamada T; Hanano M; Sugiyama Y
J Pharmacol Exp Ther; 1994 Jan; 268(1):65-73. PubMed ID: 8301595
[TBL] [Abstract][Full Text] [Related]
25. Biliary secretion of methotrexate in rats and its inhibition by probenecid.
Kates RE; Tozer TN
J Pharm Sci; 1976 Sep; 65(9):1348-52. PubMed ID: 966152
[TBL] [Abstract][Full Text] [Related]
26. Probenecid-induced effects on bile flow and biliary excretion of 3H-ouabain.
Erttmann RR; Damm KH
Arch Int Pharmacodyn Ther; 1976 Sep; 223(1):96-106. PubMed ID: 999406
[TBL] [Abstract][Full Text] [Related]
27. Methotrexate is excreted into the bile by canalicular multispecific organic anion transporter in rats.
Masuda M; I'izuka Y; Yamazaki M; Nishigaki R; Kato Y; Ni'inuma K; Suzuki H; Sugiyama Y
Cancer Res; 1997 Aug; 57(16):3506-10. PubMed ID: 9270020
[TBL] [Abstract][Full Text] [Related]
28. Use of primary rat hepatocytes in the gel entrapment culture to predict in vivo biliary excretion.
Yin J; Meng Q
Xenobiotica; 2012 May; 42(5):417-28. PubMed ID: 22106963
[TBL] [Abstract][Full Text] [Related]
29. Comparative renal excretion of VX-702, a novel p38 MAPK inhibitor, and methotrexate in the perfused rat kidney model.
Tamhane M; Chakilam AR; Jayaraj A; Thakkar V; Taft DR
Drug Dev Ind Pharm; 2010 Mar; 36(3):315-22. PubMed ID: 20170280
[TBL] [Abstract][Full Text] [Related]
30. A nonprimate animal model applicable to zidovudine pharmacokinetics in humans: inhibition of glucuronidation and renal excretion of zidovudine by probenecid in rats.
Mays DC; Dixon KF; Balboa A; Pawluk LJ; Bauer MR; Nawoot S; Gerber N
J Pharmacol Exp Ther; 1991 Dec; 259(3):1261-70. PubMed ID: 1762074
[TBL] [Abstract][Full Text] [Related]
31. [Biliary transport of organic anions in the isolated hemoglobin-free perfused rat liver (author's transl)].
Azuma H; Oshino N
Nihon Yakurigaku Zasshi; 1980 Sep; 76(5):307-19. PubMed ID: 7203273
[TBL] [Abstract][Full Text] [Related]
32. Effect of colchicine-specific Fab fragments on the hepatic clearance of colchicine.
Sabouraud A; Redureau M; Gires P; Martinet M; Scherrmann JM
Drug Metab Dispos; 1993; 21(6):997-1002. PubMed ID: 7905405
[TBL] [Abstract][Full Text] [Related]
33. Probenecid-impaired biliary excretion of acetaminophen glucuronide and sulfate in the rat.
Savina PM; Brouwer KL
Drug Metab Dispos; 1992; 20(4):496-501. PubMed ID: 1356724
[TBL] [Abstract][Full Text] [Related]
34. Characterization of methotrexate transport and its drug interactions with human organic anion transporters.
Takeda M; Khamdang S; Narikawa S; Kimura H; Hosoyamada M; Cha SH; Sekine T; Endou H
J Pharmacol Exp Ther; 2002 Aug; 302(2):666-71. PubMed ID: 12130730
[TBL] [Abstract][Full Text] [Related]
35. In vivo biliary clearance should be predicted by intrinsic biliary clearance in sandwich-cultured hepatocytes.
Nakakariya M; Ono M; Amano N; Moriwaki T; Maeda K; Sugiyama Y
Drug Metab Dispos; 2012 Mar; 40(3):602-9. PubMed ID: 22190695
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic modeling of the hepatobiliary transport mediated by cooperation of uptake and efflux transporters.
Kusuhara H; Sugiyama Y
Drug Metab Rev; 2010 Aug; 42(3):539-50. PubMed ID: 20175646
[TBL] [Abstract][Full Text] [Related]
37. Interaction of valproic acid and carbapenem antibiotics with multidrug resistance-associated proteins in rat erythrocyte membranes.
Ogawa K; Yumoto R; Hamada N; Nagai J; Takano M
Epilepsy Res; 2006 Sep; 71(1):76-87. PubMed ID: 16806827
[TBL] [Abstract][Full Text] [Related]
38. Impact of Mrp2 on the biliary excretion and intestinal absorption of furosemide, probenecid, and methotrexate using Eisai hyperbilirubinemic rats.
Chen C; Scott D; Hanson E; Franco J; Berryman E; Volberg M; Liu X
Pharm Res; 2003 Jan; 20(1):31-7. PubMed ID: 12608533
[TBL] [Abstract][Full Text] [Related]
39. Dramatic increase in hepatic and biliary curcumin exposure by modulation of its elimination pathway in rats.
Lee JH; Kim HG; Oh JH; Lee YJ
J Pharm Pharmacol; 2013 Mar; 65(3):423-9. PubMed ID: 23356851
[TBL] [Abstract][Full Text] [Related]
40. Hepatic clearance and biliary secretion of protoporphyrin in the isolated, in situ-perfused rat liver.
Avner DL; Berenson MM
J Lab Clin Med; 1982 Jun; 99(6):885-94. PubMed ID: 7077129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
